Megan Price, MSN, APRN, FNP-C, Virginia Seery, CRNP, MSN, Laura Wood, RN, MSN, OCN
The practice of using combinations of drugs in chemotherapy is not new and continues to evolve to include immune checkpoint inhibitors. Drug combinations can be more effective than single-agent therapy and may also reduce the risk of developing resistance. However, combining multiple drugs may increase the risk of drug interactions. Please join Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they discuss how they have a conversation with their patients about the benefits and risks of using drug combinations in anticancer therapy.
In 2005, the Institute of Medicine published “From Cancer Patient to Cancer Survivor: Lost in Transition.” The report highlights the long-term medical and psychosocial consequences of cancer treatment and provides a foundation for survivorship programs today.